Gendius is a company that aims to bring pharmaceuticals and health economics, through clinical research and evidence, to the mobile health market. Their latest innovation, Intellin, is an intelligent remote management diabetes platform, with over 140,000 downloads so far. The COVID-19 crisis has highlighted the need for remote home monitoring of patients, and the company feels that its product is a suitable contender in this domain. Intellin has a reliable connection to over 150 medical devices and apps, and also consists of a two-way communication setup with a healthcare professional via a secure dashboard. Gendius is registered as an approved vendor with AstraZeneca in Saudi Arabia and looks to establish deeper relations with the National Health Service (UK) to create a demand for its product. The company will use the investment to scale its business globally, drive commercialisation, offer an opportunity to its stakeholders, and target venture capital.
days to go:
Expired
investment:
£386,829
Pharmafair is an online marketplace for the pharmaceutical supply chain, from the wholesaler to the end consumer. The company estimates that the pharmaceutical market in the UK is worth £43 billion, and it aims to be a major contender in this segment. It plans to use stock exchange trading models to enhance the feel, liquidity and functionality of its application. Its app will also have the ability to list the sale or request purchase of a product and show live news feeds, watchlists, and price alerts in the pharma industry. The company is looking to raise between £75,000 and £100,000 for pre/post-launch marketing and working capital to improve its application further.
days to go:
Expired
investment:
£273
The Park Brewery (TPB) is a beer manufacturer. The company raised over £300,000 in its crowdfunding campaign in 2018. It has also managed to increase its sales from 100 pubs to 200. The company's beer is distributed around the UK via eight wholesalers. It also has onboarded notable clients like The Hilton, Honest Burgers, Fullers, and many more. TPB argues that it performed well despite Covid-19. It set up an e-commerce site and sold its products Direct-to-Customers (DTC), having completed around 2,000 home deliveries and gained over 1,700 new customers in 2020 throughout the lockdown. It will use the investment to develop its marketing strategy, increase direct sales, enhance its range, create more employment, and purchase additional tank space to meet demand.
days to go:
Expired
investment:
£229,999
Docandu is an innovative digital health platform designed both for patients & doctors, making digital healthcare accessible from anywhere. Docandu aims to be a key tech health service provider, starting from Greece, improving the existing national and private health care services. The global digital health market is estimated to be worth $536 Billion by 2025. To date, they have developed two separate apps for doctors and patients. They have also received an angel investment of 100,000 Euros and sponsorship of $25,000 from Microsoft. The company has initiated early-stage relationships with a couple of Greek public and private health entities. With the proceeds, they will execute their go-to-market strategy and make global health ID a reality, by expanding its affiliate network of doctors, health providers and public health systems.
days to go:
Expired
investment:
£70,900
White Peak Distillery (WPD) is a whisky distillery that aims to change the way whisky is made and create authentic flavours. It has so far invested £1.4 million in tried and tested plant equipment producing 400,000 bottles of maturing whisky. The company aims to become a contender in the $60 billion global premium whisky market. WPD has received 'Gold Awards' from The Wizards of Whisky World Whisky Awards. It has come out with programs to monetise its maturing whisky including its Cask Sales program, Temperance Club membership and its Prologue 2.1 release 2-year aged single malt spirit, that has been received with positive feedback. WPD has also been awarded visitor business in The Peak District, which receives 13 million+ visitors per annum, boosting its Direct-to-Consumer (D2C) model. It will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£1,301,320
Rightangled is a healthcare technology company backed by NHS England & regulated by the Care Quality Commission (CQC). It began its journey as a platform that would enable the use of genetic information within the medical practice, in an accurate, streamlined, and affordable way. It gradually established itself as a healthcare provider for screening and diagnostic services. Its Heart DNA Test project, launched in 2017, is helping patients minimize their cardiac risks and enabling doctors to have a complete risk profile for their patients. The project was appreciated and received funding from NHS England. Its next project, Fitness DNA Test, tapped into the fitness and wellbeing markets. Recently, in the wake of the COVID-19 threat, the company has developed a home-based throat swab test to detect the viral infection, by testing viral load presented in its nucleic acid material within (RNA). For its efforts, Rightangled has been featured on CNN, Sky News, LBC radio, Sky News radio, and Newsweek. With the investment, the company aims to release a mobile application by the end of 2020, and develop an AI system to give instant tailored health, diet, and fitness advice to its users based on the data gathered from patient-doctor interactions and patient responses.
days to go:
Expired
investment:
£522,689
Doisy & Dam (D&D) is a confectionery challenger brand that produces a range of dark chocolate products. It claims that its products are sold across the UK and stocked by Amazon, Sainsbury's, Holland & Barrett, Ocado, Boots, and other global markets. D&D's products are created using ethically sourced cocoa, natural ingredients and contain no traces of palm oil. The company aspires to become a contender in the UK confectionery market that was worth £3.9 billion in April 2021. It further points out that people are aware of the health and the sustainability credentials of the products they buy. It intends to target this sentiment and become an established brand. The company states it has grown its sales to over £1 million and aspires to become the best dark chocolate confectioner in the UK. D&D state they will use the investment for marketing, expanding its product range, and growing its export business.
days to go:
Expired
investment:
£515,735
Symmetrical Power has developed an innovative solution that addresses the issue of energy wastage. After identifying the inefficiency of the 3 Phase Electrical Distribution Boards, Symmetrical Power is creating the ‘Intelligent Distribution Board’ (ID Board). It aims to prevent the challenge of peak demand whilst saving on energy bills. The working model of the product also received positive feedback from electrical specialists. Additionally, Symmetrical Power was also a Shell Springboard regional finalist (2018) for its new low-carbon ideas. With the proceeds, the company will complete design & begin distribution in Europe and to position itself as the go-to Distribution Board provider.
days to go:
Expired
investment:
£233,600
The Ethical Butcher (TEB) is a premium, sustainable and ethical online butcher on a mission to spearhead the craft meat revolution. It has partnered with farmers who practise regenerative agriculture and supplies premium quality meat to the restaurant industry throughout London. TEB claims that its meat is 100% pasture-fed and free from hormones and antibiotics. It has served 10,500 orders to 5,000 customers. TEB generated £789,000 in revenue and £141,000 in profit in 2020. TEB asserts that it has an ‘Excellent’ rating on Trustpilot, featured on news entities such as The Telegraph, The Times, and BBC Good Food, and claims to be the first and only online Pasture-Fed Livestock Association (PFLA) certified butcher in London. The company points out that it has 478,000 website visitors and intends to use the investment to accelerate the growth of its B2C business and scale its meat production.
days to go:
Expired
investment:
£1,592,648
Wellbeing Sisters (WS) is a company that offers wellbeing advice, hosts an online shop, and sells a subscription box full of toxin-free health, beauty, and nutritional products by and for women. The company first launched its subscription box in 2019 for women trying to conceive. WS witnessed a sell-out of its series of one-off boxes tailored towards conceiving, pregnancy, early motherhood, midlife and menopause in 2020. WS aims to be a contender in the UK subscription box market that is set to be worth £1 billion by 2022. The company asserts that it has organically grown its social media following consisting of over 5,000 supporters. It will use the investment to invest in technology, product development, and marketing/PR.
days to go:
Expired
investment:
£153,394
